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Abstract 
Nutritional care of surgical infants and children is of major importance. This is for several 
reasons: (i) body stores are often smaller and more precarious; (ii) infants and children not 
only require energy for maintenance, but also for growth; and (iii) as in adults, recovery from 
surgery is faster in those patients who are adequately nourished. Survival of infants with 
congenital anomalies dramatically improved following the introduction of parenteral 
nutrition. However, infection and cholestasis remain problematic for parenterally fed infants 
and children. 
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Background 
Nutrition is especially important to surgical infants and children, firstly because of smaller body 
stores and relatively higher energy expenditure, and secondly because of the requirement for 
growth and adequate neurodevelopment. Energy stores are only adequate for ~2 days at 24-25 
weeks gestation, increase to ~20 days at term as glycogen and fat stores increase (1) and are in 
excess of 50 days in the adult, hence the urgent need for adequate caloric intake in preterm 
infants after birth. Full-term neonates have higher content of endogenous fat (approximately 
600g) and therefore can tolerate a few days of undernutrition. Nevertheless, adequate nutrition 
in excess of basic requirements, i.e. enough to support growth, should be instituted as soon as 
practicable. Although adults following surgery or trauma have increased energy requirements 
(2), there is no strong evidence that increased energy should be provided to septic or surgical 
neonates (3), or to older children requiring surgery. Target enteral calories are as indicated in 
Table 1. 
 
The optimum nutritional route is oral enteral feeding, however, artificial enteral feeding or 
parenteral nutrition (PN) may be required if adequate oral feeds cannot be tolerated. The basic 
principle underlying choice of feeding routes is that the most physiological route safely 
possible should be used: gastric feeds are preferred over jejunal feeds, enteral feeds are 
preferred over parenteral feeds etc. 
 
Growth monitoring 
Artificial enteral nutrition and PN are both nutritional interventions, and nutritional outcomes 
should be assessed in order to determine the effectiveness of these interventions. Growth of 
all paediatric surgical patients, especially those receiving artificial nutritional support, should 
be monitored longitudinally using appropriate charts, currently the UK-WHO growth charts, 
0-18 years available from the Royal College of Paediatrics and Child Health.  
 
Artificial enteral feeding  
Indications 
The simplest artificial route likely to be encountered by paediatric surgeons is the naso- or 
oro- gastric tube given to premature infants for immaturity of swallowing. Other indications 
for artificial enteral feeds are: delayed gastric emptying, gastroesophageal reflux, impaired 
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intestinal motility, Crohn’s disease, neurological or metabolic co-morbidity, intensive 
care/ventilation. 
Route 
The administration route can be naso- or oro- gastric or jejunal tubes, gastrostomy, gastro-
jejunostomy or surgical jejunostomy tubes. Gastric feeding is preferable to intestinal feeding 
because it allows for a more natural digestive process i.e. allows action of salivary and gastric 
enzymes and the antibacterial action of stomach acid, in addition to the use of the stomach as a 
reservoir. Gastric feeding is associated with a larger osmotic and volume tolerance and a lower 
frequency of diarrhoea and dumping syndrome. Thus, transpyloric feeds are usually restricted to 
infants or children (i) unable to tolerate naso- or oro- gastric feeds; (ii) at increased risk of 
aspiration; (iii) with anatomical contra-indications to gastric feeds. Neonates are obligatory nose 
breathers and therefore oro-gastric feeding may be preferable over naso-gastric feeding in 
preterm infants to avoid upper airway obstruction. However, naso- gastric tubes are easier to 
secure and may involve a lower risk of displacement. In infants requiring gastric tube feeding 
for extended periods (e.g. more than 6-8 weeks) it is advisable to insert a gastrostomy, to 
decrease the negative oral stimulation of repeated insertion of nasal or oral tubes. The tube can 
be inserted using an open, laparoscopic or percutaneous endoscopic (PEG) approach. In infants 
with significant gastro-oesophageal reflux, fundoplication with gastrostomy tube or enterostomy 
tube placement is indicated (4), although some authors favour gastrojejunal tube over 
fundoplication plus gastrostomy (5). There is no strong evidence to prefer any of these 
therapeutic approaches over any other.  
Selection of enteral feeds 
Breast milk is the ideal feed for infants because it has specific anti-infectious activities, aids 
gastro-intestinal maturation and neurological development. When breast milk is not available 
chemically defined formulae can be used, which are designed either for preterm infants, term 
infants, or older children.  If malabsorption is present and persists, an appropriate specific 
formula should be introduced, such as soy-based disaccharide-free feed for disaccharide 
intolerance, medium chain triglyceride (MCT) formula for fat malabsorption, elemental (free 
amino acids) or semi-elemental (protein hydrolysate containing di- and tri- peptides) formula 
for severe malabsorption due to short bowel syndrome or severe mucosal damage as in NEC. 
For persistent severe malabsorption, a modular diet may be necessary, in which glucose, 
amino acid and MCT preparations are provided separately. 
Administration of enteral feeds 
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Enteral feeds can be administered as boluses, continuous feeds or combination of the 
two. Bolus feeds are more physiological and stimulate intestinal motility, enterohepatic 
circulation of bile acids and gallbladder contraction. Bolus feeds mimic or supplement meals 
and are easier to administer than continuous feeds since a feeding pump is not required. 
Where bolus feeds are not tolerated, for example in the presence of gastro-oesophageal 
reflux, continuous feeds should be administered via an infusion pump over 24 hours. Infants 
and children with jejunal tubes should receive continuous feeds and not bolus feeds as the 
stomach is no longer providing a reservoir.  
Complications of enteral tube feeding 
Complications can be mechanical including leakage, tube blockage, tube displacement or 
migration and intestinal perforation. Although infection is less of a risk than with PN, the 
risk of infected enteral feeds should not be ignored, and the gastrostomy/jejunostomy site can 
become infected. Other complications involve the gastrointestinal tract. These include: 
gastro-oesophageal reflux with aspiration pneumonia, dumping syndrome and diarrhoea. 
Jejunostomy tubes inserted at laparotomy can be also associated with intestinal obstruction.  
 
In surgical infants and children, enteral feeding often results in vomiting, interruption of 
feeding, and inadequate calorie intake. In infants with congenital gastrointestinal anomalies, 
exclusive enteral feeding is commonly precluded for some time after surgery due to large 
gastric aspirates and intestinal dysmotility, so calorie intake is established initially by PN (see 
below). Enteral feeding is introduced when intestinal motility and absorption improves. The 
percentage of calories given enterally is gradually increased at the expense of intravenous 
calorie intake. This transition time from total PN to total enteral feeding could be quite long. 
The presence of gastric aspirate often induces clinicians and surgeons not to use the gut for 
nutrition. However, minimal enteral feeding (trophic feeding) can be implemented early in 
these patients. These minimal feeds may prevent gut mucosal atrophy, increase intestinal 
blood flow, improve activity of digestive enzymes and thus ‘prime’ the gut for subsequent 
higher volume, nutritive feeds. Although enteral nutritional adequacy (‘full enteral feeds’) is 
usually assessed as enteral volume/calorie tolerance, it should be borne in mind that tolerance 
is not the same as absorption, as infants and children may require a significant period of time 
for intestinal adaptation to allow complete absorption of administered feeds. Growth 
monitoring following full enteral nutritional tolerance therefore remains necessary. In infants 
and children with stomas, frequent urinary electrolyte measurements are particularly 
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important. Low urinary sodium with normal serum sodium suggests active sodium 
conservation. As sodium is important for growth, sodium supplementation may be 
appropriate in this scenario (6). 
 
Parenteral nutrition 
Indications  
PN should be utilised when enteral feeding is impossible, inadequate or hazardous, but should 
be given for the shortest period of time possible and the proportion of nutrition given 
enterally increased as tolerated. Energy reserves are such that stable term infants can tolerate 
3-4 days without enteral feeds, and older children 7-10 days, before starting PN, if it is 
anticipated that enteral nutrition may be resumed within this time. Premature neonates have 
smaller energy reserves and the time before introducing PN is much shorter.  
The most frequent indications in paediatric surgery are intestinal obstruction due to congenital 
anomalies, although acquired conditions may require PN for variable lengths of time. Although 
infants with some neonatal surgical conditions, such as gastroschisis, are all likely to receive 
PN, there are some other congenital anomalies where the use of PN is more controversial, for 
example duodenal atresia, in which many surgeons would routinely initiate PN, whereas some 
surgeons preferentially manage patients without PN by the use of trans-anastomotic tubes (7). In 
addition to congenital bowel obstruction, PN may also be used in cases of post-operative ileus, 
necrotizing enterocolitis, short-bowel syndrome, gastroenterological indications, and respiratory 
co-morbidity. 
Route 
PN must be administered via centrally placed catheters (including peripherally inserted 
central catheters (i.e. PICC lines), surgically placed central catheters or centrally-placed 
umbilical catheters), as peripheral administration gives significant risk of complications from 
hyperosmolar glucose, which can cause vascular irritation or damage and thrombosis. Central 
catheter choice depends on catheters already in place, and the length of time over which PN is 
anticipated (3). 
Components of parenteral nutrition  
The caloric needs for PN are provided by carbohydrate and lipid. Protein is required for growth 
and not used as a source of calories, since the catabolism of protein to produce energy is an 
uneconomic metabolic process compared to the oxidation of carbohydrate and fat which 
produces more energy at a lower metabolic cost. The ideal PN regimen therefore should provide 
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enough amino acids for protein turnover and tissue growth, and sufficient calories to 
minimise protein oxidation for energy.  
Fluid requirements  
The hydration and proportion of extracellular fluid changes rapidly in the neonate. In a 
surgical infant, these changes will also be occurring simultaneously with surgical intervention 
and initiation of PN. Fluid overload is a possibility in these infants, and careful consideration 
of all fluids administered (PN and other prescribed drugs), together with daily monitoring of 
weight and electrolytes is mandatory, at least until PN has been stabilised. Excessive fluid 
administration can result in pulmonary oedema, or failure of closure of patent ductus 
arteriosus. A recent report highlighted the poor fluid management of many neonates receiving 
PN (8). Fluid restriction, or a requirement to administer other fluids in significant volume, 
can result in the delivery of macronutrients being less than current recommendations. 
 
PN should include- 
- carbohydrate (up to 18g/kg/d in infants <10kg, up to 12g/kg/d in older children). Glucose is 
a main energy source for body cells and should be the primary energy substrate in PN, 
covering 60-70% of non-protein calories (3) 
- lipid emulsion (up to 3g/kg/d), Lipids provide an energy-dense, isotonic alternative to 
glucose as an energy source, which also prevent essential fatty acid deficiency and facilitate 
provision of fat soluble vitamins. Combined infusion of glucose and lipids confers metabolic 
advantages over glucose, because it lowers the metabolic rate and carbon dioxide production 
and increases the efficiency of energy utilisation. 
- amino acids (up to 3g/kg/d in infants, and 1.5-2.0g/kg/d in older children), In contrast to 
healthy adults who exist in a state of neutral nitrogen balance, infants and children need to be 
in positive nitrogen balance in order to achieve satisfactory growth and development. Preterm 
infants who are receiving glucose alone lose protein quickly (at the rate of 1-2% body protein 
per day), so should start to receive at least 1-1.5 g/kg/d amino acids parenterally if not 
receiving EN. 
- electrolytes (sodium 2-4mmol/kg/d infants, 1-3 in children; potassium 0-3mmol/kg/d). 
Other electrolytes (chloride, calcium, phosphate) are very dependent on the clinical condition 
of the patient and technical pharmacy aspects of stability and compounding, 
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- vitamins. Both lipid soluble (vitamins A,D,E,K) and water soluble vitamins (vitamin B 
complex, C, pantothenate, biotin and folic acid) are added to paediatric PN, usually as 
commercially available mixtures,  
- iron and trace elements (zinc, copper, manganese, selenium, fluoride and iodide) are usually 
added to paediatric PN of longer than a few days duration. Again, they are available as 
commercially mixtures, 
- water is necessary to decrease osmolality of the solution, quantity depends on fluid status of 
the patient. 
The caloric requirement of a PN-fed patient is approximately 10-20% lower than that of 
enterally-fed patients (i.e. calories indicated in Table 1) because stool and other losses are 
minimal. PN is usually given 24 hours a day, but with a 4 hour suspension of lipid infusion to 
allow triglyceride clearance. 
Complications are frequent in patients on PN: 
- Mechanical catheter complications e.g. thrombosis, incorrect position/ displacement etc. 
Extravasation of PN solution is a common complication of peripheral PN. Unfortunately, even a 
low osmolarity solution is detrimental for peripheral veins leading to inflammation and 
extravasation of the solution, which can cause tissue necrosis and infection. Intravenous lines 
may become clogged from thrombus formation, calcium precipitates, or lipid deposition. 
- Metabolic e.g. hyper or hypoglycaemia, hypertriglyceridaemia, electrolyte alterations. 
- Fluid overload e.g. oedema, failure of closure of PDA. 
- Infection - catheter, bacterial translocation etc. More than 50% of surgical infants on PN 
have at least one suspected episode of sepsis, and around 30% of surgical neonates having at 
least one positive blood culture (9, 10). Although catheter-borne infections, which can be 
reduced by rigorous precautions, such chlorhexidine antisepsis (10), are important, microbial 
translocation from the intestine is also a significant source of infection in surgical infants on 
PN.   
- Cholestasis - The commonest hepatobiliary complication of PN is cholestasis (PN-
associated cholestasis; PNAC). The clinical significance of this cholestasis itself is unknown, 
but if untreated, intestinal failure associated liver disease (IFALD) may occur, which can 
result in the need for liver transplantation, or can result in death. The incidence of PNAC  
depends on the length of time on PN, and occurs in around 60% of infants receiving PN for 
longer than 2 months (11). Various clinical factors contribute to the development of PNAC,  
including prematurity, low birth weight, duration of PN, immature entero-hepatic circulation, 
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intestinal microflora, septicaemia, failure to implement enteral nutrition, short-bowel 
syndrome due to resection, and number of laparotomies (reviewed (12)). Infants with 
gastroschisis or jejunal atresia seem to be at particular risk. PNAC and IFALD are diagnoses 
of exclusion without any specific marker, so a diagnostic work-up for other potential causes 
of elevated bilirubin, e.g. inborn errors of metabolism, biliary atresia, choledochal cyst, is 
necessary. The aetiology of PNAC/IFALD remains unclear; possible causes include the 
toxicity of components of PN, lack of enteral feeding, continuous non-pulsatile delivery of 
nutrients and host factors, infection and sepsis (12). In particular, the lipid component of PN 
has been implicated and many units now use alternative lipid management strategies such as: 
(i) decreasing the amount of lipid administered; (ii) use of a lipid emulsion of 10% fish oil; 
(iii) use of lipid emulsions containing a mixture of long- (LCT) and medium-chain (MCT) 
triglycerides; (iv) use of mixed lipid emulsions such as mixtures of Soybean, Medium-chain, 
Olive and Fish triglycerides. In addition to lipid management, careful management of these 
patients under a multi-disciplinary team seems to be beneficial (13). Bowel lengthening 
procedures, such as the STEP procedure or longitudinal intestinal lengthening may help 
transition to enteral nutrition (14), whereas in those with advanced liver disease and no 
prospect of enteral autonomy, transplantation may be considered.  
Careful monitoring on patients on PN is mandatory. This is particularly important during the 
period over which PN is introduced. Full blood count, electrolytes, blood gases, 
urea/creatinine, glucose, calcium/phosphate, albumin, liver function tests (especially 
bilirubin), and cholesterol/triglycerides should all be monitored, together with vitamins and 
trace elements for long-term PN patients. PN should not be a “one size fits all” prescription, 
but individual tailoring is recommended, dependent on clinical status, monitoring results and 
introduction of enteral nutrition. 
 
Conclusion and Future Directions  
Nutrition of surgical infants and children is complicated by the requirement for growth. 
Inadequate or unbalanced nutrition may lead to future problems for these children, and we are 
now able to start to improve nutrition delivery in order to optimise outcomes as well as survival. 
Despite advances in nutritional care, such as the multi-disciplinary approach, complications 
such as sepsis and cholestasis remain relatively frequent. Future research should be aimed 
towards the prevention and treatment of these complications of artificial nutritional support.  
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Table 1: 
Age of child target caloric intake (kcal/ 
kg/ d) 
males females 
Premature 110 - 120 110 - 120 
0 - 1 mth 113 107 
1 - 3 mths 100 97 
3 mths -1 year 80 80 
1 - 4y 82 78 
5 - 8y 73 70 
9 -13y 64 58 
14 – 18y 53 47 
 
